
GRAS Assessment Navigator
Assess ingredient safety claims and build FDA-aligned GRAS safety dossiers
What You Can Do
You can systematically assess whether food ingredients qualify for GRAS (Generally Recognized As Safe) status by analyzing scientific evidence, toxicology data, and regulatory precedent. This skill helps you identify gaps in your safety case, determine the optimal submission pathway (notification vs. non-notification), and structure a compelling dossier that meets FDA expectations for GRAS determinations.
Features
assess ingredient eligibility against GRAS pathways (expert consensus or pre-1958 use history)
identify missing toxicology, chemistry, or use data that weakens your safety case
organize safety data, qualified expert reports, and regulatory arguments in FDA-compliant format
benchmark against similar ingredients with approved GRAS determinations to strengthen your submission
determine whether confidential or notified GRAS status aligns with your regulatory and commercial goals
evaluate relevant animal studies, human safety data, and dose-response relationships
structure arguments for qualified expert panels to evaluate your safety assessment
ensure your dossier meets current FDA GRAS Notice Form FDA 2570 requirements
Example Output
Example 1: Evidence Gap Analysis
- Ingredient: Novel plant extract for beverage use
- Current data: Acute toxicity studies (rats), microbial testing
- Gaps identified: Chronic toxicity study (90-day), genotoxicity assessment, intended use level justification
- Recommendation: Commission 90-day rat study before submission to strengthen qualified expert consensus
Example 2: GRAS Pathway Assessment
- Ingredient: Historical spice with pre-1958 food use documentation
- Pathway determination: Pre-1958 common use pathway viable
- Supporting evidence: Market records, historical food use documentation, regulatory precedent (GRAS determinations for similar spices)
- Submission recommendation: Non-notification pathway with documented historical use and safety literature review
Example 3: Dossier Structure Plan
- Section I: Identity and specifications of the ingredient
- Section II: Manufacturing process and impurity profile
- Section III: Intended conditions of use and exposure estimates
- Section IV: Safety literature review and toxicology summary
- Section V: Qualified expert panel consensus statement
- Status: Ready for FDA submission once expert panel signs consensus letter
What's Included
- GRAS Assessment Navigator SKILL.md: core framework for systematic safety evaluation
- GRAS Eligibility Checklist: step-by-step criteria for pre-1958 use and expert consensus pathways
- Evidence Gap Template: structured format for identifying missing toxicology or chemistry data
- Safety Dossier Outline: FDA Form FDA 2570-compliant structure for organizing submission materials
- Precedent Research Framework: methodology for benchmarking against similar approved GRAS determinations
- Qualified Expert Guidance: structuring safety assessment arguments for expert panel consensus
Who It's For
- Food regulatory specialists and compliance officers evaluating ingredient safety submissions
- R&D teams planning GRAS determinations for new food ingredients or novel uses
- Toxicologists and safety scientists structuring scientific cases for FDA submission
- Ingredient suppliers seeking GRAS approval pathways for market differentiation
- Regulatory consultants advising food companies on GRAS strategy and dossier preparation
Best For
- Initial GRAS eligibility assessments for new ingredients or intended uses
- Identifying toxicology or chemistry data gaps before commissioning expensive studies
- Structuring and organizing safety evidence into FDA-compliant submission packages
- Determining optimal GRAS pathway (notification vs. non-notification) based on available evidence
- Benchmarking safety cases against similar ingredients with approved GRAS determinations
- Preparing qualified expert panel guidance for consensus safety assessments







